A Combination of Alectinib and DNA-Demethylating Agents Synergistically Inhibits Anaplastic-Lymphoma-Kinase-Positive Anaplastic Large-Cell Lymphoma Cell Proliferation
Kazunori Kawasoe(Saga University), Shinya Kimura(Saga University)
Cited by 3
Related Papers
2-Hydroxypropyl-β-Cyclodextrin Acts as a Novel Anticancer Agent
|PLoS ONE|2015|77
The MEK inhibitor trametinib separates murine graft-versus-host disease from graft-versus-tumor effects
|JCI Insight|2016|26